AMA CPT® Assistant - 2006 Issue 1 (January)

Multiple Molecular Marker Array-Based Evaluation (January 2006)

January 2006 pages 5-6 Coding Communication:Multiple Molecular Marker Array-Based Evaluation Knowledge of the role that genetic mutations play in neoplastic and non-neoplastic disease together with the number of implicated genetic aberrations continues to increase, driven, in part, by new analytic methods. One of these is arraybased technology, which provides a platform that is rapidly advancing the study of molecular diagnostic abnormalities associated with a number of different diseases. Results from this testing are used to interpret, diagnose, and monitor disease states and to direct therapeutic intervention. They may also identify preclinical and carrier states to identify patients predisposed to...

To read the full article, sign in and subscribe to the AMA CPT® Assistant.


Access to this feature is available in the following products:
  • AMA's CPT® Assistant - Current + Archives
  • AMA's CPT® Advanced Coding Pack
CPT® Assistant content is the official source for CPT® coding guidance. It is an instrumental tool when appealing insurance denials and validating coding to auditors. Monthly issues and an extensive archive provide comprehensive guidance on proper CPT® coding for past, present and upcoming code set releases. Archives date back to 1990 for historical use of codes, changes, rationales, coding tips and trends in the industry.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.